SELLAS (SLS): Buy the Post-Noise Dip — A Mid-Run Swing Trade Into Clinical Catalysts
SELLAS Life Sciences (SLS) is a small clinical-stage oncology shop trading at $11.66 after a pullback tied to a regulatory/investor probe story. The setup is a swing trade: buy the dip into improving technical support, leverage an elevated short-interest backdrop and upcoming potential readouts, while sizing for binary clinical and legal risk. Entr…